Virax Biolabs Group Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Virax Biolabs Group Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1727% to $156,419. Profit margin reached -4305%. Total operating expenses were $6,547,063.

Profit Margin

Virax Biolabs Group Limited (NASDAQ:VRAX): Profit margin
2020 99.87K -801.13K -802.13%
2021 123.82K -650.98K -525.75%
2022 0 -1.70M
2023 8.56K -5.45M -63748.32%
2024 156.41K -6.73M -4304.81%

VRAX Income Statement (2020 – 2024)

2024 2023 2022 2021 2020
Revenue
Revenue
156.41K8.56K0123.82K99.87K
Cost of revenue
105.82K9.92K0133.25K54.12K
Gross profit
50.59K-1.36K0-9.43K45.74K
Operating exp.
Research and development
1.56M397.10K433.74K120.22K87K
Selling and marketing
026.61K13.81K57.20K7.69K
Total operating expenses
6.54M5.73M1.73M635.10K696.99K
Operating income
-6.49M-5.73M-1.73M-644.54K-651.24K
Other income (expenses), net
-242.64K274.99K-16.19K-28.37K-88.22K
Income before tax
-6.73M-5.45M-1.74M-672.91K-739.46K
Income tax expense
0-271-1.77M-666.46K61.66K
Net income
-6.73M-5.45M-1.70M-650.98K-801.13K
Earnings per share
Basic EPS
-3.36-5.13-1.5-0.57-0.7
Diluted EPS
-3.36-5.13-1.5-0.57-0.7
Data sourceData sourceData source